Endometrial stromal sarcomas
- 1 August 1977
- Vol. 40 (2) , 898-906
- https://doi.org/10.1002/1097-0142(197708)40:2<898::aid-cncr2820400246>3.0.co;2-x
Abstract
This study is a clinicopathologic evaluation of seven patients with endometrial stromal sarcoma of pure homologous type. Histologic distinction from endometrial stromatosis was based on the presence of high mitotic activity and nuclear anaplasia. One sarcoma appeared to have originated from invasive stromatosis. All patients died within 27 months although the tumor was judged to have been confined to the uterus at the time of hysterectomy in five patients. The aggressive clinical behavior and high mortality rate documented in this and other studies indicate that stromal sarcoma should be distinguished from the better differentiated and more indolent endometrial stromal tumor known as stromatosis or endolymphatic stromal myosis. It is suggested that surgery be supplemented by irradiation and/or chemotherapy as primary treatment for stromal sarcoma in view of its dismal prognosis. Cancer 40:898–906, 1977.This publication has 9 references indexed in Scilit:
- ENDOMETRIAL STROMATOSIS OF UTERUS1977
- Adriamycin and bleomycin, alone and in combination, in gynecologic cancersCancer, 1973
- Uterine sarcomasHuman Pathology, 1970
- Radiotherapy in the treatment of sarcomas of the corpus uteriCancer, 1969
- Sarcoma of the uterusAmerican Journal of Obstetrics and Gynecology, 1966
- Sarcoma of the UterusObstetrics & Gynecology, 1962
- Mesenchymal sarcomas of the uterusAmerican Journal of Obstetrics and Gynecology, 1959
- UTERINE SARCOMAS: HISTOGENESIS AND TAXONOMYAnnals of the New York Academy of Sciences, 1959